CGMP/Active Pharmaceutical Ingredient (API)/Adulterated/Misbranded
Similar Posts
Supreme Deli LLC Voluntarily Recalls Boar’s Head Pecorino Romano Cheese Because of Possible Health Risk
Supreme Service Solutions LLC. (dba Supreme Deli) is assisting in a recall for items purchased from Boar’s Head Brand’s supplier of pecorino romano cheese. Ambriola Company, has issued a recall for select SKUs of pecorino romano cheese products, including two products they produce under the Boar’s HFirst and Last Bakery, LLC Recalls First and Last Brand Tomato Sauce Products Because Of Possible Health Risk
First and Last Bakery, LLC of Hartford, CT, is recalling the following products due to a possible health risk identified by the Connecticut Department of Consumer Protection.
• First and Last Original Marinara Sauce, Tomato & Basil
• First and Last Original Traditional Pasta Sauce, Meat FlavoredFDA Roundup: January 19, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.Sarfez Pharmaceuticals, Inc. – 708901 – 04/25/2025
False & Misleading Claims/MisbrandedComplex Innovative Trial Design Meeting Program
As displayed in the Federal Register notice on August 1, 2018, FDA is conducting a Complex Innovative Designs (CID) Meeting Program to support the goal of facilitating and advancing the use of complex adaptive, Bayesian, and other novel clinical trial designs, as highlighted in the sixth iteration oDrug Development Tool Qualification Process: Transparency Provisions
Under the 21st Century Cures Act enacted on December 13, 2016, the new section 507 Qualification of Drug Development Tools was added to the Federal Food, Drug, and Cosmetic Act and formally establishes an updated, multi-stage process for DDT qualification. This process includes three submission mil
